证券代码：300715 证券简称：凯伦股份 公告编号: 2025-042 江苏凯伦建材股份有限公司 第五届监事会第十五次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，不存在 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏凯伦建材股份有限公司（以下简称"公司"或"本公司"）第五届监事 会第十五次会议于 2025 年 5 月 13 日在公司会议室以现场方式召开，会议通知以 专人送达方式于 2025 年 5 月 8 日向各位监事发出，本次会议应参加监事 3 名， 实际参加监事 3 名，会议由监事会主席胡晓丽女士主持。本次会议的召开符合《公 司法》等有关法律、法规及《公司章程》的规定。 二、监事会会议审议情况 三、备查文件 《江苏凯伦建材股份有限公司第五届监事会第十五次会议决议》。 特此公告。 江苏凯伦建材股份有限公司 监事会 2025 年 5 月 13 日 经与会监事审议，形成了如下决议： （一）审议通过《关于 2025 年度日常关联交易预计的议案》 经审核，监事会认为：公司 2025 年度预计的日常关联交易符合公司业务发 展和经营需求，属于正常的商业交易行为，关联交易遵循 ...

| 保荐人名称：中天国富证券有限公司 | 被保荐公司简称：凯伦股份 | | --- | --- | | 保荐代表人姓名：陈杰 | 联系电话：0755-33522821 | | 保荐代表人姓名：陈定 | 联系电话：0755-33522821 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0次 | | 2.督导公司建立健全并有效执行规章制度的 | | | 情况 | | | （1）是否督导公司建立健全规章制度（包 | | | 括但不限于防止关联方占用公司资源的制 | 是 | | 度、募集资金管理制度、内控制度、内部审 | | | 计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 不适用，凯伦股份募集资金专户均于2022年12月 | | | 31日前销户完毕。 | | （2）公司募集资金项目进展是否与信息披 | | | 露文件一致 | 是 | ...

关于江苏凯伦建材股份有限公司 | 门提交的工作计划和报告等（如适用） | | | --- | --- | | 5.审计委员会是否至少每季度向董事会报告一次内部审计工作 | √ | | 进度、质量及发现的重大问题等（如适用） | | | 6.内部审计部门是否至少每季度向审计委员会报告一次内部审 | | | 计工作计划的执行情况以及内部审计工作中发现的问题等 | √ | | （如适用） | | | 7.内部审计部门是否至少每季度对募集资金的存放与使用情况 √ | | | 进行一次审计（如适用） | | | 8.内部审计部门是否在每个会计年度结束前二个月内向审计委 | √ | | 员会提交次一年度内部审计工作计划（如适用） | | | 9.内部审计部门是否在每个会计年度结束后二个月内向审计委 | √ | | 员会提交年度内部审计工作报告（如适用） | | | 10.内部审计部门是否至少每年向审计委员会提交一次内部控 | √ | | 制评价报告（如适用） | | | 11.从事风险投资、委托理财、套期保值业务等事项是否建立了 | √ | | 完备、合规的内控制度 | | | （三）信息披露 | | | 现场检查手段： ...

关于江苏凯伦建材股份有限公司 向特定对象发行股票之持续督导保荐总结报告书 中天国富证券有限公司（以下简称"中天国富证券"）作为江苏凯伦建材股 份有限公司（以下简称"凯伦股份"或"公司"）向特定对象发行股票项目的保 荐机构，对凯伦股份履行持续督导义务，持续督导期限自 2021 年 6 月 22 日至 2024 年 12 月 31 日。目前持续督导期限已满，中天国富证券现根据《证券发行 上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》《深圳证券交 易所上市公司自律监管指引第 13 号——保荐业务》等相关规定，出具本持续督 导保荐总结报告书。 中天国富证券有限公司 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 2、本保荐机构及本保荐代表人自愿接受中国证监会、深圳证券交易所对保 荐总结报告书相关事项进行的任何质询和调查。 3、本保荐机构及本保荐代表人自愿接受中国证监会按照《证券发行上市保 荐业务管理办法》及《深圳证券交易所上市公司自律监管指引第 13 号——保荐 业务》的有关 ...

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]

Group 1 - National Integrated Circuit Industry Fund plans to reduce its stake in Jiangbolong by no more than 4,159,815 shares, accounting for 1.00% of the total share capital, between May 27, 2025, and August 26, 2025 [1] - The reduction is due to the fund's operational management needs and will be executed through centralized bidding at market prices [1] - The implementation of this reduction plan will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1] Group 2 - Haitai Weiye has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue no more than 710.52 million overseas listed ordinary shares [2] - The listing will take place on the main board of the Hong Kong Stock Exchange, but the matter still carries uncertainties [2] Group 3 - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection starting May 1, 2025, which is expected to negatively impact sales revenue [3] - The drug generated approximately RMB 210 million in sales for the year 2024, representing 29% of the company's total sales revenue [3] - The price adjustment may lead to a risk of single product loss for the drug in 2025 [3] Group 4 - Xinyuan Technology's director expressed inability to guarantee the authenticity and completeness of the 2024 annual report and related financial documents, citing significant issues identified by the audit firm [4] - The company has received a notice of investigation from the securities regulatory authority, and the audit report issued was unable to express an opinion [4] Group 5 - ST Xinchao announced that its stock will be suspended from trading starting May 6, 2025, due to the inability to disclose the audited 2024 annual report and the 2025 Q1 report within the legal timeframe [5] - If the company fails to disclose the 2024 annual report within two months of the suspension, it will face delisting risk warnings [5] Group 6 - Huakang Clean has pre-won a project worth RMB 167 million [6] - Tongguang Cable has pre-won a procurement project from the State Grid valued at RMB 142 million [6] - Fengmao Co. has increased its investment in a production base in Thailand to RMB 26 million [6] Group 7 - Huaren Pharmaceutical's wholly-owned subsidiary has obtained a medical device registration certificate for wound dressings [7] Group 8 - Major shareholders of Kairun Co. plan to reduce their holdings by no more than 9 million shares [10] - CITIC Securities has completed its reduction plan for China Gold [10] - The reduction plan for Hengfeng Information's director and vice president has been completed [10]

证券代码：300715 证券简称：凯伦股份 公告编号:2025-039 江苏凯伦建材股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏。 一、担保情况概述 江苏凯伦建材股份有限公司（以下简称"公司"、"保证人"）第五届董事会 第十六次会议和 2024 年年度股东大会审议通过了《关于为全资子公司提供担保 的议案》，同意公司为全资子公司唐山凯伦新材料科技有限公司（以下简称"唐 山凯伦"、"债务人"、"借款人"）提供总额不超过人民币 45,000 万元的连带保证 责任，担保期限自公司 2024 年度股东大会审议批准之日起至下一年度股东大会 止，同时授权公司董事长或董事长的授权人签署相关法律合同及文件。具体内容 详见 2025 年 4 月 19 日刊登在中国证监会指定的创业板信息披露网站上的《关于 为全资子公司提供担保的公告》。 二、担保进展情况 本次担保属于已审议通过的担保事项范围，且担保金额在公司已审议通过的 担保额度范围内，无需再次提交公司董事会及股东大会审议。 三、被担保人情况 （一）基本情况 | 公司名称 | 唐 ...

证券代码：300715 证券简称：凯伦股份 公告编号:2025-038 江苏凯伦建材股份有限公司 关于持股 5%以上股东减持股份的预披露公告 公司股东卢礼珺保证向本公司提供的信息内容真实、准确、完整，不存在虚 假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 一、股东的基本情况 | 股东名称 | 持有公司股份数量(股) | 占剔除公司回购专户股份后 | | --- | --- | --- | | | | 总股本比例 | | 卢礼珺 | 27,232,000 | 7.35% | 注：公司当前总股本 378,055,430 股，扣除公司当前回购专用证券账户中的股份数量后 为 370,270,070 股。本公告中出现合计数尾数与各分项数字之和尾数不一致的，为"四舍五 入"所致。 二、本次减持计划的主要内容 1、减持原因：股东自身资金需求安排。 2、减持股份来源：协议转让受让的股份、二级市场购买的股份。 3、减持数量及比例：卢礼珺女士减持数量不超过 9,000,000 股，不超过公 司目前剔除回购专用账户中股份数量后的总股本的 2.43%。 若减持计划期间有送股、资本 ...

二、进展情况 证券代码：300715 证券简称：凯伦股份 公告编号:2025-037 江苏凯伦建材股份有限公司 佳智彩于近日完成了上述股权交割事项的工商变更登记并取得《营业执照》， 具体登记信息如下： 关于收购苏州佳智彩光电科技有限公司 51%股权 完成工商变更登记取得营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存在 虚假记载、误导性陈述或重大遗漏。 一、交易概述 江苏凯伦建材股份有限公司（以下简称"公司"）于 2025 年 4 月 2 日、2025 年 4 月 21 日分别召开第五届董事会第十五次会议、第五届监事会第十二次会议 及 2025 年第一次临时股东大会,审议通过了《关于现金收购苏州佳智彩光电科技 有限公司 51%股权暨关联交易的议案》，同意公司以现金方式收购苏州佳智彩光 电科技有限公司（以下简称"佳智彩"）股东苏州矽彩光电科技有限公司（以下 简称"矽彩光电"）、苏州工业园区苏纳同合纳米技术应用产业基金合伙企业（有 限合伙）（以下简称"苏纳同合"）、南通嘉鑫一期股权投资基金合伙企业（有限 合伙）（以下简称"嘉鑫一期"）合计持有的佳智彩 51%股权。本次购买股权事项 完 ...

证券代码：300715 证券简称：凯伦股份 公告编号:2025-036 江苏凯伦建材股份有限公司 关于公司相关方承诺事项履行情况的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏。 一、承诺基本情况 江苏凯伦建材股份有限公司(以下简称"公司")于2021年10月22日收到公司 董事长钱林弟先生、董事李忠人先生、董事张勇先生、董事季歆宇先生（以下简 称"承诺人"）的出具的《承诺函》。主要内容为：为解决恒大集团及其成员企业 向公司购买防水卷材、涂料等产品业务中出现的商业承兑汇票逾期未兑付问题， 承诺人承诺，对截至2021年10月22日公司应收恒大集团及其成员企业的应收账款 及应收票据余额合计18,832.72万元，如在2022年12月31日前无法足额兑付，由 此造成的资产减值损失由承诺人承担，并在2023年-2025年分期支付，每年支付 比例为实际损失金额的20%、30%和50%，支付时间为年度审计报告出具后60个工 作日内。具体内容详见公司于2021年10月23日披露的《关于收到公司实际控制人、 董事承诺函的提示性公告》。 截止2022年12月31日，上 ...